Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.4K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.3K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.3K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.7K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.7K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

5.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.8K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

4.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.2K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

934
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
934

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Hail, Not Frail! MA's Wellness Reach Expands.

Managed care (Langhorne, Pa.)·2019
Same authorSame journal

Thanks to CMS Rule Change, MA Takes SDOH to a Whole New Level.

Managed care (Langhorne, Pa.)·2019
Same author

A Conversation with Jennifer Graff, National Pharmaceutical Council VP. Real-World Evidence Might Take a Decade to be Fully Established.

Managed care (Langhorne, Pa.)·2019
Same author

HIV/AIDS treatment drastically reduces mortality and helps limit transmission.

Managed care (Langhorne, Pa.)·2019
Same author

Why the new opioid bill won't really change the way insurers approach the epidemic.

Managed care (Langhorne, Pa.)·2019
Same author

Ah, Look at All the Lonely People (And Resultant Health Problems Thereof).

Managed care (Langhorne, Pa.)·2018
Same journal

To Be Continued:The Search for a Cure for HIV.

Managed care (Langhorne, Pa.)·2019
Same journal

Once-a-day HIV Treatment: Pricey But Perhaps Worth It.

Managed care (Langhorne, Pa.)·2019
Same journal

In Trump, HIV/AIDS Groups Find an Ally Who's Tough To Love.

Managed care (Langhorne, Pa.)·2019
Same journal

Air Ambulance Turbulence: Consolidation, Cost Shifting, and Surprise Billing.

Managed care (Langhorne, Pa.)·2019
See all related articles

Related Experiment Video

Updated: Mar 18, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K

Prediabetes Pilot Lands CMS Expansion

Frank Diamond

    Managed Care (Langhorne, Pa.)
    |June 29, 2016
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
    06:46

    A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

    Published on: July 5, 2022

    3.4K
    Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms
    08:16

    Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms

    Published on: March 15, 2024

    2.3K

    Related Experiment Videos

    Last Updated: Mar 18, 2026

    Improving IV Insulin Administration in a Community Hospital
    12:08

    Improving IV Insulin Administration in a Community Hospital

    Published on: June 11, 2012

    19.5K
    A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
    06:46

    A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

    Published on: July 5, 2022

    3.4K
    Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms
    08:16

    Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms

    Published on: March 15, 2024

    2.3K